Home › Metastatic Cancer › Florida › Fort Lauderdale
Metastatic Cancer clinical trials in Fort Lauderdale, FL
3 studies for Metastatic Cancer are looking for participants at sites in and around Fort Lauderdale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Helios Clinical Research, Fort Lauderdale
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecruitingPhase 3
- Broward Health Medical Center, Fort Lauderdale
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- Holy Cross Hospital (site 213), Fort Lauderdale
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Fort Lauderdale
- Non-Small Cell Lung Cancer12 studies
- Cancer (all types)7 studies
- Lung Cancer7 studies
- Heart Failure6 studies
- Macular Degeneration5 studies
- Ovarian Cancer4 studies
- Breast Cancer4 studies
- Multiple Myeloma3 studies
- Blood Cancers3 studies
- Chronic Kidney Disease3 studies
- Cardiovascular Disease3 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.